Natural feedstocks for diversity-oriented synthesis

Information

  • Research Project
  • 7109033
  • ApplicationId
    7109033
  • Core Project Number
    R42GM072158
  • Full Project Number
    2R42GM072158-02
  • Serial Number
    72158
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/1/2004 - 20 years ago
  • Project End Date
    4/30/2008 - 16 years ago
  • Program Officer Name
    LEES, ROBERT
  • Budget Start Date
    5/1/2006 - 18 years ago
  • Budget End Date
    4/30/2007 - 17 years ago
  • Fiscal Year
    2006
  • Support Year
    2
  • Suffix
  • Award Notice Date
    4/28/2006 - 18 years ago

Natural feedstocks for diversity-oriented synthesis

[unreadable] DESCRIPTION (provided by applicant): This Phase II STTR application is a continuation of a previous Phase I award between the Wright group at Dartmouth College and Promiliad Biopharma. The goal of this application is to continue our efforts to develop novel chemical libraries with the diversity and complexity common to natural products as a marketable product to the pharmaceutical industry. Key to our strategy is the use of fermentation derived natural products and recombinant non-natural variants as high complexity feedstock materials for diversity oriented synthesis. Unlike analog generation, these recombinant natural products are specifically designed to allow chemical diversification. Our approach differs substantially from combinatorial biosynthesis in that only a few, well-defined compounds are needed from fermentation sources. By only requiring a limited set of recombinant compounds from the organism, careful optimization can be conducted to ensure high yields of material. While this strategy relies on nature to construct a high degree of the complex features of the library, diversity-oriented strategies are utilized to generate large libraries that cover vast areas of structural space. Under the Phase I award, we have developed a number of direct and efficient strategies for converting a recombinant building block (nonactate) into several unique molecular architectures. This Phase award will allow our efforts to transition from the methods stage to Phase III, large-scale production and marketing of compound libraries. Under this award we will (1) prepare moderate sized libraries of highly diverse and complex molecules from nonactate, (2) develop new methods for scaffolds generation from the polyketides methymycin, pikromycin and spinosyn and (3) develop two new recombinant natural feedstocks, pikrodiene and spinosene. Through these efforts, Promiliad will be in a position to become a major supplier of new chemical entities to the pharmaceutical industry. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R42
  • Administering IC
    GM
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    517214
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:517214\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PROMILIAD BIOPHARMA, INC.
  • Organization Department
  • Organization DUNS
    130194082
  • Organization City
    ALBERTON
  • Organization State
    MT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    598200010
  • Organization District
    UNITED STATES